Response to Comment on "A small-molecule antivirulence agent for treating Clostridium difficile infection"

Kristina Oresic Bender; Megan Garland; Matthew Bogyo

doi:10.1126/scitranslmed.aaf3410

Response to Comment on "A small-molecule antivirulence agent for treating Clostridium difficile infection"

Sci Transl Med. 2016 Dec 21;8(370):370tr2. doi: 10.1126/scitranslmed.aaf3410.

Authors

Kristina Oresic Bender¹, Megan Garland¹, Matthew Bogyo²

Affiliations

¹ Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA.
² Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA. [email protected].

PMID: 28003551
DOI: 10.1126/scitranslmed.aaf3410

Abstract

Ebselen's antivirulence activity in Clostridium difficile infection is likely due to multiple modes of action, but the contribution of each to its efficacy remains unclear.

Publication types

Comment

MeSH terms

Clostridioides difficile*
Clostridium Infections*
Humans